OPMEDIC GROUP releases Androtest(TM) a new andropause screening panel aimed to improve men's health in their aging years



    
    /NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR
    DISSEMINATION IN THE UNITED STATES/
    

    MONTREAL, June 16 /CNW Telbec/ - OPMEDIC GROUP INC. ("OPMEDIC GROUP")
(TSX: "OMG"), a healthcare-related services company in fertility, laboratories
and surgeries providing services and facilities to patients and surgeons
through a network of private clinics in the province of Québec, is pleased to
announce that it has developed through its division PROCREA Cliniques a new
test panel called Androtest(TM). The Androtest(TM) offers a complete screening
profile as an aid to the diagnosis and the management of andropause, an
age-related condition that affects men over 45 years of age due to a decline
in testosterone levels (late onset hypogonadism or andropause).
    The Androtest(TM) includes an extended panel of biochemical markers and a
sophisticated follow-up report that will help the physician with the patient's
medical history diagnose andropause.
    Besides the decrease in sex drive that is often the main reason for a
medical consultation by men, recent studies show that the hormonal unbalance
caused by andropause increases a man's risk of coronary artery disease,
depression, lack of energy and mental acuity in addition to a decrease in bone
mass and an increase in abdominal fat.

    
    The symptoms that may be associated with andropause may include one or
    more of the following :

    - Hot flashes and excessive sweating without physical activity
    - Loss of muscle and bone mass and strength
    - Lack of energy with diminished physical activity
    - Joint and muscle pain
    - Abdominal obesity
    - Sadness, irritability, and overall lack of interest
    - Depression
    - Sleep problems
    - Decline in mental acuity, concentration and short term memory
    - Loss of sex drive, leading to a decrease in performance and sexual
      activities
    

    "The aging man has been neglected both in research and public health
interventions which have almost exclusively focused on the treatment of
chronic diseases. The addition of Androtest(TM) to our line of laboratory
services further confirms the objective of PROCREA Cliniques to offer our
patients and physicians the most advanced clinical services in the area of
men's health.", commented Dr. Pierre St-Michel, CEO and president of Opmedic
Group.

    About OPMEDIC GROUP

    OPMEDIC GROUP is a company incorporated under the laws of the Province of
Québec which provides healthcare-related services including surgical and
endoscopic facilities and services to patients and surgeons (with its OPMEDIC
division), fertility treatments, medical imaging, laboratory services and
diagnostic procedures (with its PROCREA Cliniques division) and sperm banking
services (with its PROCREA Cryopreservation Centre subsidiary). OPMEDIC
GROUP's Common Shares trade on the Toronto Stock Exchange under the symbol
"OMG".

    This news release does not constitute an offer to sell or to solicitation
of an offer to buy any security and shall not constitute an offer,
solicitation or sale in any jurisdiction in which such offering would be
unlawful. This news release contains certain forward-looking statements that
reflect the current views and/or expectations of OPMEDIC GROUP with respect to
its performance, business and future events. Such statements are subject to a
number of risks, uncertainties and assumptions. Actual results and events may
vary significantly.

    The Content of this press release has not been approved by nor submitted
    to the TSX which assumes no liability therefore.




For further information:

For further information: Paulo Bouça, Vice President Business
Development and Chief Operating Officer, (514) 345-8535, x 2254,
pbouca@opmedicgroup.com; Renmark Financial Communications: Maurice Dagenais,
mdagenais@renmarkfinancial.com; Christine Stewart,
cstewart@renmarkfinancial.com; Montreal - (514) 939-3989, Fax: (514) 939-3717;
Toronto - (416) 644-2020, Fax.: (416) 644-2021; www.renmarkfinancial.com

Organization Profile

Opmedic Group Inc.

More on this organization


Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

CNW Membership

Fill out a CNW membership form or contact us at 1 (877) 269-7890

Learn about CNW services

Request more information about CNW products and services or call us at 1 (877) 269-7890